Drug Metabolism and Pharmacokinetics

ADME / DMPK Services. Supporting early drug discovery and late-stage drug development with state-of-the-art technologies.

Drug Metabolism and
Pharmacokinetics Support

in vitro ADME and biotransformation
to support drug discovery and development.

US Map 1200px

Expert support for your early discovery to IND enabling and clinical DDI studies.

Customizable DMPK/ADME solutions for seamless drug discovery. 

IN VITRO ADME

  • Aqueous solubility
  • Metabolic stability (microsomes,S9, hepatocytes, recombinant enzymes, plasma, tissue, etc.)
  • Blood cell partitioning
  • Protein binding (RED, UC, UF)
  • Reaction phenotyping (CYP, UGT, CES)
  • Permeability (Caco-2 & MDCK) CYP induction & inhibition (Direct & TDI)
  • Drug transporter substrate & inhibition (P-gp, BCRP, OATP1B1, OATP1B3, OAT1, OAT3, OCT1, MATE1, MATE2-K)
  • UGT inhibition
  • Metabolite identification & profiling in multiple species (in vitro and in vivo)
  • MIST assessment development

IN VITRO ADME

  • Aqueous solubility
  • Metabolic stability (microsomes,S9, hepatocytes, recombinant enzymes, plasma, tissue, etc.)
  • Blood cell partitioning
  • Protein binding (RED, UC, UF)
  • Reaction phenotyping (CYP, UGT, CES)
  • Permeability (Caco-2 & MDCK)
    CYP induction & inhibition (Direct & TDI)
  • Drug transporter substrate & inhibition (P-gp, BCRP, OATP1B1, OATP1B3, OAT1, OAT3, OCT1, MATE1, MATE2-K)
  • UGT inhibition
  • Metabolite identification & profiling in multiple species
    (in vitro and in vivo)
  • MIST assessment development

IN VIVO RODENT PK

  • Commercially available rat and mouse models
  • Fast turnaround, cost-efficient, and highly customized solutions
  • Comprehensive routes of delivery
    (IV, PO, SC, IM, IP, IN, dermal)
  • Formulation screening
  • Sparse and serial sample collection
  • Tissue, urine, CSF collection for biodistribution
  • PBMC preparation
  • Dedicated bioanalytical support for all therapeutic drug modalities
  • Non-compartmental analysis using industry standard Phoenix
  • WinNonlinTM
    Expert advice & consultation
Malvern LC MS Labs 2023 04

Why work with Resolian?

  • Our flexibility allows changes up 24 hours before the start of a study 
  • Real-time communication with the sponsor
  • We provide consistent, dependable, reproducible quality data
  • Customized study design and report

Our Drug Metabolism and Pharmacokinetics Resources

Scroll to Top
Zhao. Resolian Bioanalytics and Analytical Sciences.

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

 

Patrick Bennett. Resolian Bioanalytics and Analytical Sciences.

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.